Vaccine News and Research

Latest Vaccine News and Research

London School of Hygiene & Tropical Medicine creates International Diagnostics Centre

Today sees the launch of the International Diagnostics Centre (IDC), a global research collaboration hub, created at the London School of Hygiene & Tropical Medicine to undertake innovative research on the development and deployment of new diagnostic tests that enable patients to be diagnosed faster, more accurately and cost effectively.

8 Nov 2012

Texas Biomed develops rapid, less expensive route to screen suitable tests for bioterror threats

Texas Biomedical Research Institute scientists in San Antonio have developed a faster, less expensive route to screen suitable tests for bioterror threats and accelerate the application of countermeasures.

7 Nov 2012

WHO survey shows low knowledge level, acceptance of polio vaccine among Pashtun Pakistanis

"Polio will never be eradicated in Pakistan until a way is found to persuade poor Pashtuns to embrace the vaccine, according to a study released by the World Health Organization" in its November bulletin, the New York Times reports.

7 Nov 2012

Loyola announces 2012 Junior and Senior Scientist of the Year during St. Albert's Day

Katherine L. Knight, PhD, one of the nation's leading immune system researchers, has been named 2012 Senior Scientist of the Year at Loyola University Chicago Stritch School of Medicine. Sakthivel Sadayappan, PhD, FAHA, who is doing groundbreaking research on a protein that is critical for the normal functioning of the heart, has been named 2012 Junior Scientist of the Year.

7 Nov 2012

Sabin initiates Part II of Na-GST-1 vaccine Phase I hookworm trial

The Sabin Vaccine Institute (Sabin) today announced the start of Part II of its Phase I clinical trial of the Na-GST-1 vaccine candidate, marking another major milestone in the progress toward developing a human hookworm vaccine.

6 Nov 2012

Alnylam third quarter 2012 revenues decrease to $16.8 million

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter 2012, and company highlights.

6 Nov 2012

PsiOxus receives UK government grant to initiate ColoAd1 Phase I/II trial for ovarian cancer

PsiOxus Therapeutics, Ltd., a development stage biotechnology company, today announced the award of a £1.7 million ($2.7 million) grant from the UK government-backed Biomedical Catalyst to initiate a Phase I/II clinical trial to assess the use of ColoAd1 in the treatment of platinum-resistant, recurrent ovarian cancer.

5 Nov 2012

WHO reports on global diphtheria-tetanus-pertussis vaccination efforts

"Four in five children (83 percent) worldwide received the recommended three doses of diphtheria-tetanus-pertussis (DTP) vaccine during infancy in 2011, according to new data released in the Morbidity and Mortality Weekly Report and in the WHO Weekly Epidemiological Record (WER)," a WHO media note reports.

3 Nov 2012

Blog reports on meeting of world's largest HIV vaccine research network

KPLU 88.5's "Humanosphere" blog reports on a meeting of the HIV Vaccine Trials Network (HVTN), "the world's largest HIV vaccine research network," held in Seattle this week. "We actually don't know what the agenda is," HVTN Executive Director Jim Kublin said during a lecture, titled "Scientific Agenda, the Next Seven Years," according to the blog.

3 Nov 2012

Two research groups present data on Pressure BioSciences' PCT Platform at HUPO 2012

Pressure BioSciences, Inc. today announced that scientists from two separate research groups presented data at the recent HUPO 11th Annual World Congress (Boston, MA) indicating that the incorporation of the Company's Pressure Cycling Technology Platform into their sample preparation processes resulted in a marked improvement in the quality and/or efficiency of test results.

3 Nov 2012

Bristol-Myers Squibb welcomes decision by NICE to recommend Yervoy for advanced melanoma

Today, Bristol-Myers Squibb is pleased to welcome the decision by The National Institute for Health and Clinical Excellence (NICE) to recommend Yervoy (ipilimumab) for the treatment of previously-treated advanced (unresectable or metastatic) melanoma within the Final Appraisal Determination (FAD).

3 Nov 2012

'Details of implementation' critical to reaching goal of AIDS-free generation

Noting the progress made since the beginning of the HIV/AIDS epidemic and the upcoming recognition of World AIDS Day on December 1, Ronald Valdiserri, deputy assistant secretary for health, infectious diseases at the Department of Health and Human Services, writes in a Public Health Reports opinion piece, "We would do well to keep in mind the following caution. No matter the elegance of the controlled trial, the statistical significance of the results, or the superiority of the science, we must confront this inevitable reality: We will never be able to take full advantage of our progress in HIV clinical and prevention science until we develop and sustain the human, organizational, and structural capacities necessary to implement these new scientific breakthroughs."

3 Nov 2012

Pregnant women in rural Ghana are now getting health information via mobile phone

Pregnant women in rural Ghana are now getting health information via mobile phone. The pilot project is part of an international initiative to employ mobile technology to improve the health of people in developing countries.

3 Nov 2012

MH6 vaccine shows promise in treating meth addiction

Scientists at The Scripps Research Institute (TSRI) have performed successful tests of an experimental methamphetamine vaccine on rats. Vaccinated animals that received the drug were largely protected from typical signs of meth intoxication.

2 Nov 2012

New data: 4 in 5 children received recommended doses of DTP vaccine during infancy in 2011

Four in five children (83%) worldwide received the recommended three doses of diphtheria-tetanus-pertussis (DTP) vaccine during infancy in 2011, according to new data released in the Morbidity and Mortality Weekly Report and in the WHO Weekly Epidemiological Record (WER).

2 Nov 2012

CDC report outlines international influenza activities

The Centers for Disease Control and Prevention (CDC) on Monday released a 268-page annual report that "profiles a wide range of CDC influenza-related projects around the world, from flu surveillance in Indonesia to vaccine effectiveness studies in El Salvador and epidemiology training in Ghana," CIDRAP News reports.

1 Nov 2012

Novartis resumes distribution of two seasonal influenza vaccines in Canada

Novartis Pharmaceuticals Canada Inc. has announced it is resuming distribution of two seasonal influenza vaccines in Canada, Fluad and Agriflu, following the announcement by Health Canada earlier today that it has completed its review of safety information for Agriflu and Fluad and is releasing the two vaccines for immediate use.

1 Nov 2012

Advaxis updates preliminary data from ADXS-HPV Phase 2 trial on cervical cancer

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, updated preliminary data from an ongoing randomized 110 patient Phase 2 trial of ADXS-HPV being conducted in India in women with recurrent/refractory cervical cancer who have failed previous cytotoxic therapy.

1 Nov 2012

Benaroya Research Institute at Virginia Mason wins Grand Challenges Explorations grant

Benaroya Research Institute at Virginia Mason (BRI) announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.

1 Nov 2012

All health care workers should be vaccinated with annual flu vaccine to protect patients

All health care workers in health care institutions should be vaccinated with the annual influenza vaccine to protect patients, argues an editorial in CMAJ (Canadian Medical Association Journal).

30 Oct 2012

Vaccine News and Research

Latest Vaccine News and Research

London School of Hygiene & Tropical Medicine creates International Diagnostics Centre

Texas Biomed develops rapid, less expensive route to screen suitable tests for bioterror threats

WHO survey shows low knowledge level, acceptance of polio vaccine among Pashtun Pakistanis

Loyola announces 2012 Junior and Senior Scientist of the Year during St. Albert's Day

Sabin initiates Part II of Na-GST-1 vaccine Phase I hookworm trial

Alnylam third quarter 2012 revenues decrease to $16.8 million

PsiOxus receives UK government grant to initiate ColoAd1 Phase I/II trial for ovarian cancer

WHO reports on global diphtheria-tetanus-pertussis vaccination efforts

Blog reports on meeting of world's largest HIV vaccine research network

Two research groups present data on Pressure BioSciences' PCT Platform at HUPO 2012

Bristol-Myers Squibb welcomes decision by NICE to recommend Yervoy for advanced melanoma

'Details of implementation' critical to reaching goal of AIDS-free generation

Pregnant women in rural Ghana are now getting health information via mobile phone

MH6 vaccine shows promise in treating meth addiction

New data: 4 in 5 children received recommended doses of DTP vaccine during infancy in 2011

CDC report outlines international influenza activities

Novartis resumes distribution of two seasonal influenza vaccines in Canada

Advaxis updates preliminary data from ADXS-HPV Phase 2 trial on cervical cancer

Benaroya Research Institute at Virginia Mason wins Grand Challenges Explorations grant

All health care workers should be vaccinated with annual flu vaccine to protect patients

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in